Time filter

Source Type

Port Adelaide, Australia

Chaptini C.,Flinders Medical Center Adelaide | Sidhu S.,Royal Adelaide Hospital Adelaide
Australasian Journal of Dermatology | Year: 2014

We report two cases of adults with urticarial dermatitis who could not be managed by a variety of treatments but who obtained good control with mycophenolate mofetil (MMF). A clinical response was seen 6-8 weeks from treatment onset and they were maintained on MMF 1g twice daily (case 1), and MMF 1g omni mane and 500mg omni nocte (case 2), with no major exacerbations for many years. MMF is an immunosuppressive agent, which is currently used off-label for many dermatological conditions. To date, there have been no studies investigating the use of MMF as a treatment for urticarial dermatitis. The cases we present suggest that MMF is an effective treatment for this condition, and we recommend that MMF be considered as a treatment option. © 2014 The Australasian College of Dermatologists. Source

Warren J.M.,Royal Adelaide Hospital Adelaide | Irish G.L.,Royal Adelaide Hospital Adelaide | Purbrick B.,Royal Darwin Hospital Tiwi | Li J.J.,University of Adelaide | And 3 more authors.
Australian Journal of Rural Health | Year: 2016

Objective: To describe and evaluate a programme where medical students designed and implemented Indigenous health placements for students with an interest in rural/Indigenous health. Design, setting and participants: In 2011, a student-led programme at the University of Adelaide was set up to give medical students the opportunity to undertake outreach trips and clinical placements in remote Indigenous communities. Twenty-four medical students attended trips to remote communities between 2012 and 2014. Here we evaluate our programme using a single-arm experimental design. Main outcome measures: Responses to questionnaire items before and after attending an outreach placement, scored on 6-point Likert scales. Results: Following their remote Indigenous health placement, participants expressed a significantly higher mean likelihood of working in an Indigenous community in the future (3.17 (2.69-3.64) versus 4.00 (3.65-4.35); P < 0.007). Furthermore, after their placement participants felt better prepared to work in Indigenous communities (mean 1.79 (1.44-2.14) versus 3.21 (2.88-3.54); P < 0.001). Conclusions: A placement programme initiated and run by medical students can provide meaningful exposure to Indigenous health. Implementation of this student-led model in other medical schools may encourage nationwide development of the Indigenous health workforce. © 2016 National Rural Health Alliance Inc. Source

Warren L.R.,A+ Network | Harley S.,Royal Adelaide Hospital Adelaide | Dutschke J.,University of Adelaide | van den Berg A.,University of Adelaide | Dobbins C.,Royal Adelaide Hospital Adelaide
ANZ Journal of Surgery | Year: 2016

Background: The aim of this study was to determine if wearing a bicycle helmet during ladder use could reduce the incidence and severity of head injury in the event of a fall. Methods: A headform model with inbuilt accelerometers was used to determine the Head Injury Criterion (HIC) score of head impact by dropping 41 helmeted and unhelmeted headforms from eight heights. These results were compared. Results: There was a statistically significant difference between averaged HIC scores in helmeted and unhelmeted drops (P < 0.001). Unhelmeted HIC scores ranged from 387 at 0.25m to 2121 at 0.6m. Helmeted HIC scores ranged from 29 at 0.25m to 1199 at 2.5m. At a height of 0.5m, the risk of severe brain injury (AIS ≥4) from direct frontal head impact is predicted to reduce from >50% to <5% with helmet use. Conclusion: There was a significant decrease in the HIC scores when helmets are used and it is likely that the benefits would be seen in the clinical setting. These results provide an argument for the use of a bicycle helmets by all ladder users, in particular those over age 50 who are at increased risk of head injuries. We recommend that bicycle helmet use be incorporated into ladder injury prevention strategies. © 2016 Royal Australasian College of Surgeons. Source

Wallett A.,Royal Adelaide Hospital Adelaide | Newland K.,Royal Adelaide Hospital Adelaide | Foster-Smith E.,SA Pathology Adelaide
Australasian Journal of Dermatology | Year: 2016

Neurological involvement is a rare extracutanenous manifestation of Sweet's syndrome. We present a novel case of radiation therapy-induced neuro-Sweet disease in a patient receiving treatment for an oral squamous cell carcinoma. © 2016 The Australasian College of Dermatologists. Source

Discover hidden collaborations